CoLaborator Kobe – the first incubator laboratory to be established in Japan by a foreign pharmaceuticals company
On June 6, 2018 the CoLaborator Kobe was inaugurated with an opening ceremony and reception bringing together more than 100 guests and participants. Located in the Biomedical Innovation Cluster, the incubator space is providing excellent conditions at competitive cost for young life science companies who are looking for a research location or collaboration space to grow their business. The first two tenants have already moved in – Epigeneron and Myoridge!
The biotech startup launched from Osaka University develops practical technologies for drug discovery target identification, and therapies for intractable diseases.
Myoridge, was formed at Kyoto University and possesses technology for creating high-quality, protein-free cardiomyocytes from iPS cells.
Bayer is looking forward to bringing in other tenants, providing each with an incubation environment where they can operate for up to three years and pursue research that may lead to collaborative relationships with diverse partners, including Bayer or other pharma companies.
The biomedical industry’s interest in Bayer’s efforts is also reflected by the large number of CoLaborator tour requests received. Among them, RIKEN President Hiroshi Matsumoto paid a courtesy call to the site.